GetTopicDetailResponse(id=ed8e11008a7, topicName=Lonsurf, introduction=Lonsurf, content=null, image=null, comments=5, allHits=1220, url=https://h5.medsci.cn/topic?id=11008, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=37567, tagList=[TagDto(tagId=37567, tagName=Lonsurf)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1548240, encodeId=a537154824029, content=<a href='/topic/show?id=ed8e11008a7' target=_blank style='color:#2F92EE;'>#Lonsurf#</a>, objectTitle=Lancet Gastroenterol Hepatol：Lonsurf聯(lián)合雷莫蘆單抗治療不可切除的晚期胃癌療效和安全性, objectType=article, longId=206331, objectId=9adb20633151, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9adb20633151, replyNumber=0, likeNumber=77, createdTime=2021-01-29, rootId=0, userName=LShY0906_98743848, userId=ff1014060425, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9adb20633151, moduleTitle=Lancet Gastroenterol Hepatol：Lonsurf聯(lián)合雷莫蘆單抗治療不可切除的晚期胃癌療效和安全性, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=9adb20633151)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1548239, encodeId=66f9154823990, content=<a href='/topic/show?id=ed8e11008a7' target=_blank style='color:#2F92EE;'>#Lonsurf#</a>, objectTitle=LONSURF將在中國上市，用于治療轉移性結直腸癌, objectType=article, longId=198320, objectId=4f79198320c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4f79198320c7, replyNumber=0, likeNumber=77, createdTime=2020-07-31, rootId=0, userName=LShY0906_98743848, userId=ff1014060425, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f79198320c7, moduleTitle=LONSURF將在中國上市，用于治療轉移性結直腸癌, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=4f79198320c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1548238, encodeId=ad7115482387f, content=<a href='/topic/show?id=ed8e11008a7' target=_blank style='color:#2F92EE;'>#Lonsurf#</a>, objectTitle=ASCO 2020年度胃腸道癌專題討論會：LONSURF和Futibatinib（TAS-120）的全新數(shù)據(jù), objectType=article, longId=186810, objectId=ee3118681049, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee3118681049, replyNumber=0, likeNumber=79, createdTime=2020-01-29, rootId=0, userName=LShY0906_98743848, userId=ff1014060425, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee3118681049, moduleTitle=ASCO 2020年度胃腸道癌專題討論會：LONSURF和Futibatinib（TAS-120）的全新數(shù)據(jù), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=ee3118681049)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1548237, encodeId=b7e5154823ee1, content=<a href='/topic/show?id=ed8e11008a7' target=_blank style='color:#2F92EE;'>#Lonsurf#</a>, objectTitle=大冢及施維雅結直腸癌復方新藥Lonsurf英國NICE批準, objectType=article, longId=75978, objectId=2011e597805, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2011e597805, replyNumber=0, likeNumber=140, createdTime=2016-08-28, rootId=0, userName=LShY0906_98743848, userId=ff1014060425, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2011e597805, moduleTitle=大冢及施維雅結直腸癌復方新藥Lonsurf英國NICE批準, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=2011e597805)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1548236, encodeId=aab415482362f, content=<a href='/topic/show?id=ed8e11008a7' target=_blank style='color:#2F92EE;'>#Lonsurf#</a>, objectTitle=FDA批準TAS-102(Lonsurf)用于治療晚期結直腸癌, objectType=article, longId=56824, objectId=8f225682468, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8f225682468, replyNumber=0, likeNumber=58, createdTime=2015-10-03, rootId=0, userName=LShY0906_98743848, userId=ff1014060425, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8f225682468, moduleTitle=FDA批準TAS-102(Lonsurf)用于治療晚期結直腸癌, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=8f225682468)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
